A Review of Male Genital Psoriasis

Clicks: 1
ID: 318635
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal

Ranked #142 of 171 articles by views in clinical and experimental dermatology

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 171 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Male genital psoriasis (mGP) is an inflammatory dermatosis affecting the penis and scrotum, a common but significantly under-reported manifestation of psoriasis. Owing to the unique anatomical and microenvironmental characteristics of the male genital region, mGP differs from chronic plaque psoriasis in its clinical presentation, exacerbating factors and therapeutic considerations. Similar to other forms of psoriasis, mGP carries a substantial psychosocial burden. This is amplified by the intimate nature of mGP and its detrimental effects on sexual and interpersonal functioning, which is often overlooked in routine consultations. This narrative review aims to summarise the presentation, consequences and management options of mGP. Assessment of disease severity is further challenged by limited body surface area involvement, leading to underestimation by conventional psoriasis severity measurement tools. Moreover, certain established treatments for psoriasis are unsuitable in mGP due to differing microanatomy and increased susceptibility to adverse effects. Despite its significant physical and psychosocial impact, mGP remains an under-recognised and under-studied subtype of psoriasis with no therapies specifically approved. Existing studies seldomly distinguish genital from inverse psoriasis, and even fewer distinguish male from female GP. The nuances of mGP merit dedicated clinical trials using validated and specific measurement tools to accurately characterise mGP and evaluate treatment efficacy.
Reference Key
openalex_W7165773370 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors India Capper, Aaron Hughes
Journal clinical and experimental dermatology
Year 2026
DOI
10.1093/ced/llag261
URL
https://doi.org/10.1093/ced/llag261
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.